Aims: Pannexins (Panx) form ATP release channels and it has been proposed that they play an important role in the regulation of vascular tone. However, distribution of Panx across the arterial vasculature is not documented. Methods: We tested antibodies against Panx1, Panx2 and Panx3 on human embryonic kidney cells (which do not endogenously express Panx proteins) transfected with plasmids encoding each Panx isoform and Panx1–/– mice. Each of the Panx antibodies was found to be specific and was tested on isolated arteries using immunocytochemistry. Results: We demonstrated that Panx1 is the primary isoform detected in the arterial network. In large arteries, Panx1 is primarily in endothelial cells, whereas in small arteries and arterioles it localizes primarily to the smooth muscle cells. Panx1 was the predominant isoform expressed in coronary arteries, except in arteries less than 100 µm where Panx3 became detectable. Only Panx3 was expressed in the juxtaglomerular apparatus and cortical arterioles. The pulmonary artery and alveoli had expression of all 3 Panx isoforms. No Panx isoforms were detected at the myoendothelial junctions. Conclusion: We conclude that the specific localized expression of Panx channels throughout the vasculature points towards an important role for these channels in regulating the release of ATP throughout the arterial network.

Keywords:
Pannexins, Vasculature, Arteries, Endothelium, Smooth muscle
1.
Panchin YV: Evolution of gap junction proteins – the pannexin alternative. J Exp Biol 2005;208:1415–1419.
2.
Baranova A, Ivanov D, Petrash N, Pestova A, Skoblov M, Kelmanson I, Shagin D, Nazarenko S, Geraymovych E, Litvin O, Tiunova A, Born TL, Usman N, Staroverov D, Lukyanov S, Panchin Y: The mammalian pannexin family is homologous to the invertebrate innexin gap junction proteins. Genomics 2004;83:706–716.
3.
Bao L, Locovei S, Dahl G: Pannexin membrane channels are mechanosensitive conduits for ATP. FEBS Lett 2004;572:65–68.
4.
Ray A, Zoidl G, Weickert S, Wahle P, Dermietzel R: Site-specific and developmental expression of pannexin1 in the mouse nervous system. Eur J Neurosci 2005;21:3277–3290.
5.
Santiago MF, Veliskova J, Patel NK, Lutz SE, Caille D, Charollais A, Meda P, Scemes E: Targeting pannexin1 improves seizure outcome. PloS One 2011;6:e25178.
6.
Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H: Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci USA 2003;100:13644–13649.
7.
Barbe MT, Monyer H, Bruzzone R: Cell-cell communication beyond connexins: the pannexin channels. Physiology (Bethesda) 2006;21:103–114.
8.
Bond SR, Lau A, Penuela S, Sampaio AV, Underhill TM, Laird DW, Naus CC: Pannexin 3 is a novel target for Runx2, expressed by osteoblasts and mature growth plate chondrocytes. J Bone Miner Res 2011;26:2911–2922.
9.
Penuela S, Celetti SJ, Bhalla R, Shao Q, Laird DW: Diverse subcellular distribution profiles of pannexin 1 and pannexin 3. Cell Commun Adhes 2008;15:133–142.
10.
Dahl G, Locovei S: Pannexin: To gap or not to gap, is that a question? IUBMB Life 2006;58:409–419.
11.
Pfahnl A, Dahl G: Gating of cx46 gap junction hemichannels by calcium and voltage. Pflugers Arch 1999;437:345–353.
12.
Quist AP, Rhee SK, Lin H, Lal R: Physiological role of gap-junctional hemichannels. Extracellular calcium-dependent isosmotic volume regulation. J Cell Biol 2000;148:1063–1074.
13.
Li H, Liu TF, Lazrak A, Peracchia C, Goldberg GS, Lampe PD, Johnson RG: Properties and regulation of gap junctional hemichannels in the plasma membranes of cultured cells. J Cell Biol 1996;134:1019–1030.
14.
Qiu F, Dahl G: A permeant regulating its permeation pore: inhibition of pannexin 1 channels by ATP. Am J Physiol Cell Physiol 2009;296:C250–C255.
15.
Ransford GA, Fregien N, Qiu F, Dahl G, Conner GE, Salathe M: Pannexin 1 contributes to ATP release in airway epithelia. Am J Resp Cell Mol Biol 2009;41:525–534.
16.
Sridharan M, Adderley SP, Bowles EA, Egan TM, Stephenson AH, Ellsworth ML, Sprague RS: Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. Am J Physiol Heart Circ Physiol 2011;299:H1146–H1152.
17.
Woehrle T, Yip L, Elkhal A, Sumi Y, Chen Y, Yao Y, Insel PA, Junger WG: Pannexin-1 hemichannel-mediated ATP release together with p2x1 and p2x4 receptors regulate T-cell activation at the immune synapse. Blood 2010;116:3475–3484.
18.
Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, D’Orleans-Juste P, Marceau F, Thorin E, Sevigny J: NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovasc Res 2010;85:204–213.
19.
Kauffenstein G, Furstenau CR, D’Orleans-Juste P, Sevigny J: The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation. Br J Pharmacol 2010;159:576–585.
20.
Forrester T, Lind AR: Identification of adenosine triphosphate in human plasma and the concentration in the venous effluent of forearm muscles before, during and after sustained contractions. J Physiol 1969;204:347–364.
21.
Mortensen SP, Gonzalez-Alonso J, Bune LT, Saltin B, Pilegaard H, Hellsten Y: ATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine. Am J Physiol Regul Integr Comp Physiol 2009;296:R1140–R1148.
22.
Bodin P, Burnstock G: Synergistic effect of acute hypoxia on flow-induced release of ATP from cultured endothelial cells. Experientia 1995;51:256–259.
23.
Bergfeld GR, Forrester T: Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovasc Res 1992;26:40–47.
24.
Bodin P, Bailey D, Burnstock G: Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells. Br J Pharmacol 1991;103:1203–1205.
25.
Sneddon P, Burnstock G: ATP as a co-transmitter in rat tail artery. Eur J Pharmacol 1984;106:149–152.
26.
Sprague RS, Ellsworth ML, Stephenson AH, Kleinhenz ME, Lonigro AJ: Deformation-induced ATP release from red blood cells requires CFTR activity. Am J Physiol 1998;275:H1726–H1732.
27.
Sneddon P, Burnstock G: Inhibition of excitatory junction potentials in guinea-pig vas deferens by alpha, beta-methylene-ATP: further evidence for ATP and noradrenaline as cotransmitters. Eur J Pharmacol 1984;100:85–90.
28.
Burnstock G: Noradrenaline and ATP as cotransmitters in sympathetic nerves. Neurochem Int 1990;17:357–368.
29.
Sneddon P, Westfall DP: Pharmacological evidence that adenosine triphosphate and noradrenaline are co-transmitters in the guinea-pig vas deferens. J Physiol 1984;347:561–580.
30.
Sprague RS, Hanson MS, Achilleus D, Bowles EA, Stephenson AH, Sridharan M, Adderley S, Procknow J, Ellsworth ML: Rabbit erythrocytes release ATP and dilate skeletal muscle arterioles in the presence of reduced oxygen tension. Pharmacol Rep 2009;61:183–190.
31.
Lew MJ, White TD: Release of endogenous ATP during sympathetic nerve stimulation. Br J Pharmacol 1987;92:349–355.
32.
Bodin P, Burnstock G: ATP-stimulated release of ATP by human endothelial cells. J Cardiovasc Pharmacol 1996;27:872–875.
33.
Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV: Endothelial cell surface f1-f0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001;98:6656–6661.
34.
Bodin P, Burnstock G: Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol 2001;38:900–908.
35.
Yamamoto K, Shimizu N, Obi S, Kumagaya S, Taketani Y, Kamiya A, Ando J: Involvement of cell surface ATP synthase in flow-induced ATP release by vascular endothelial cells. Am J Physiol Heart Circ Physiol 2007;293:H1646–H1653.
36.
Billaud M, Lohman AW, Straub AC, Looft-Wilson R, Johnstone SR, Araj CA, Best AK, Chekeni FB, Ravichandran KS, Penuela S, Laird DW, Isakson BE: Pannexin1 regulates alpha1-adrenergic receptor-mediated vasoconstriction. Circ Res 2011;109:80–85.
37.
Goedecke S, Roderigo C, Rose CR, Rauch BH, Goedecke A, Schrader J: Thrombin-induced ATP release from human umbilical vein endothelial cells. Am J Physiol Cell Physiol 2012;302:C915–C923.
38.
Mustafa SJ, Morrison RR, Teng B, Pelleg A: Adenosine receptors and the heart: role in regulation of coronary blood flow and cardiac electrophysiology. Handb Exp Pharmacol 2009:161–188.
39.
Berne RM: Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. Am J Physiol 1963;204:317–322.
40.
Burnstock G: Control of vascular tone by purines and pyrimidines. Br J Pharmacol 2010;161:527–529.
41.
Winbury MM, Papierski DH, Hemmer ML, Hambourger WE: Coronary dilator action of the adenine-ATP series. J Pharmacol Exp Ther 1953;109:255–260.
42.
Burnstock G: Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells. Pharmacol Rep 2008;60:12–20.
43.
Jones RD, Berne RM: Evidence for a metabolic mechanism in autoregulation of blood flow in skeletal muscle. Circ Res 1965;17:540–554.
44.
Drury AN, Szent-Gyorgyi A: The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol 1929;68:213–237.
45.
Rubio R, Berne RM: Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance. Circ Res 1969;25:407–415.
46.
Dobson JG Jr, Rubio R, Berne RM: Role of adenine nucleotides, adenosine, and inorganic phosphate in the regulation of skeletal muscle blood flow. Circ Res 1971;29:375–384.
47.
Nishiyama A, Rahman M, Inscho EW: Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Hypertens Res 2004;27:791–804.
48.
Erlinge D: Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 1998;31:1–8.
49.
Wang DJ, Huang NN, Heppel LA: Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J Cellul Physiol 1992;153:221–233.
50.
Penuela S, Bhalla R, Nag K, Laird DW: Glycosylation regulates pannexin intermixing and cellular localization. Mol Biol Cell 2009;20:4313–4323.
51.
Johnstone SR, Ross J, Rizzo MJ, Straub AC, Lampe PD, Leitinger N, Isakson BE: Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation. Am J Pathol 2009;175:916–924.
52.
Lee MY, Garvey SM, Baras AS, Lemmon JA, Gomez MF, Schoppee Bortz PD, Daum G, LeBoeuf RC, Wamhoff BR: Integrative genomics identifies DSCR1 (RCAN1) as a novel NFAT-dependent mediator of phenotypic modulation in vascular smooth muscle cells. Hum Mol Genet 2010;19:468–479.
53.
Kadl A, Meher AK, Sharma PR, Lee MY, Doran AC, Johnstone SR, Elliott MR, Gruber F, Han J, Chen W, Kensler T, Ravichandran KS, Isakson BE, Wamhoff BR, Leitinger N: Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via NRF2. Circ Res 2010;107:737–746.
54.
Heberlein KR, Straub AC, Best AK, Greyson MA, Looft-Wilson RC, Sharma PR, Meher A, Leitinger N, Isakson BE: Plasminogen activator inhibitor-1 regulates myoendothelial junction formation. Circ Res 2010;106:1092–1102.
55.
Haddock RE, Grayson TH, Brackenbury TD, Meaney KR, Neylon CB, Sandow SL, Hill CE: Endothelial coordination of cerebral vasomotion via myoendothelial gap junctions containing connexins 37 and 40. Am J Physiol Heart Circ Physiol 2006;291:H2047–H2056.
56.
Sandow SL, Neylon CB, Chen MX, Garland CJ: Spatial separation of endothelial small- and intermediate-conductance calcium-activated potassium channels (K(Ca)) and connexins: possible relationship to vasodilator function? J Anat 2006;209:689–698.
57.
Sandow SL, Haddock RE, Hill CE, Chadha PS, Kerr PM, Welsh DG, Plane F: What’s where and why at a vascular myoendothelial microdomain signalling complex. Clin Exp Pharmacol Physiol 2009;36:67–76.
58.
Heberlein KR, Straub AC, Isakson BE: The myoendothelial junction: breaking through the matrix? Microcirculation 2009;16:307–322.
59.
Isakson BE, Duling BR: Heterocellular contact at the myoendothelial junction influences gap junction organization. Circ Res 2005;97:44–51.
60.
Straub AC, Billaud M, Johnstone SR, Best AK, Yemen S, Dwyer ST, Looft-Wilson R, Lysiak JJ, Gaston B, Palmer L, Isakson BE: Compartmentalized connexin 43 s-nitrosylation/denitrosylation regulates heterocellular communication in the vessel wall. Arterioscler Thromb Vasc Biol 2011;31:399–407.
61.
Chekeni FB, Elliott MR, Sandilos JK, Walk SF, Kinchen JM, Lazarowski ER, Armstrong AJ, Penuela S, Laird DW, Salvesen GS, Isakson BE, Bayliss DA, Ravichandran KS: Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis. Nature 2010;467:863–867.
62.
Hopwood AM, Burnstock G: ATP mediates coronary vasoconstriction via P2X-purinoceptors and coronary vasodilatation via P2Y-purinoceptors in the isolated perfused rat heart. Eur J Pharmacol 1987;136:49–54.
63.
Ralevic V, Mathie RT, Alexander B, Burnstock G: Characterization of P2X- and P2Y-purinoceptors in the rabbit hepatic arterial vasculature. Br J Pharmacol 1991;103:1108–1113.
64.
Kennedy C, Delbro D, Burnstock G: P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery. Eur J Pharmacol 1985;107:161–168.
65.
Buvinic S, Briones R, Huidobro-Toro JP: P2Y(1) and P2Y(2) receptors are coupled to the NO/CGMP pathway to vasodilate the rat arterial mesenteric bed. Br J Pharmacol 2002;136:847–856.
66.
Raqeeb A, Sheng J, Ao N, Braun AP: Purinergic P2Y2 receptors mediate rapid Ca(2+) mobilization, membrane hyperpolarization and nitric oxide production in human vascular endothelial cells. Cell Calcium 2011;49:240–248.
67.
Woodward HN, Anwar A, Riddle S, Taraseviciene-Stewart L, Fragoso M, Stenmark KR, Gerasimovskaya EV: Pi3k, Rho, and ROCK play a key role in hypoxia-induced ATP release and ATP-stimulated angiogenic responses in pulmonary artery vasa vasorum endothelial cells. Am J Physiol Lung Cell Mol Physiol 2009;297:L954–L964.
68.
Mohrman DE, Heller LJ: Cardiovascular Physiology, ed 3. New York, McGraw Hill, 1991, pp 175–188.
69.
Kukulski F, Ben Yebdri F, Lecka J, Kauffenstein G, Levesque SA, Martin-Satue M, Sevigny J: Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 2009;46:166–170.
70.
Bours MJ, Dagnelie PC, Giuliani AL, Wesselius A, Di Virgilio F: P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. Front Biosci (Schol Ed) 2011;3:1443–1456.
71.
Erlinge D, Burnstock G: P2 receptors in cardiovascular regulation and disease. Purinergic Signal 2008;4:1–20.
72.
Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, Dagnelie PC: Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 2006;112:358–404.
73.
Bruzzone R, Barbe MT, Jakob NJ, Monyer H: Pharmacological properties of homomeric and heteromeric pannexin hemichannels expressed in xenopus oocytes. J Neurochem 2005;92:1033–1043.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.